INNOVA SARS-CoV-2 Antigen Rapid Tests Recalled for Unauthorized Non-Clinical Distribution
INNOVA Medical Group is recalling SARS-CoV-2 antigen rapid test kits distributed to customers not enrolled in an authorized clinical investigation.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recall classification requires a minimum severity score of 4 per rubric rules. Although the recall is for unauthorized distribution (a regulatory compliance violation), no illnesses, injuries, or deaths are reported in the source text, preventing a higher score despite the Class I classification.
Plain-English summary
INNOVA Medical Group, Inc. is recalling the '25T 888 SARS-CoV-2 Antigen' rapid qualitative test kits (REF BT1309). The recall involves 1,945 boxes containing approximately 48,625 individual tests distributed nationwide and internationally.
The FDA classified this as a Class I recall because the test kits were distributed to customers who were not enrolled in an authorized clinical investigation. The kits are labeled 'For In Vitro Diagnostic Use Only' and are designed for use under clinical supervision.
The affected test kits were distributed to 32 U.S. states as well as Canada, India, and the United Kingdom. Affected lot numbers include U2101750, U2101751, X2006004, X2008001, X2008010, X2009002, X2009004, X2009013, X2009016, X2010004, X2010010, and multiple additional lots from the X2011, X2012, and X2101 series (for the complete list, consult the FDA recall notice).
Consumers with affected test kits should discontinue use immediately. Contact INNOVA Medical Group, Inc. or the product's distributor for instructions on returning the kits or obtaining a replacement.
The recalled product
- Product
- For In Vitro Diagnostic Use Only *** 25T 888 SARS-CoV-2 Antigen *** SARS-CoV-2 Antigen Rapid Qualitative Test *** REF BT1309
- Manufacturer
- INNOVA MEDICAL GROUP, INC.
- Hazard
- improper-use
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- HighPhilips Azurion X-Ray Systems Table Movement Control Defect Recall
FDA (Devices) · 2026-05-27
- HighAzurion X-ray System Deaeration Hose May Degrade and Cause Oil Leakage
FDA (Devices) · 2026-05-27
- HighMedtronic DLP Retrograde Cannula Cardiopulmonary Bypass Catheter Recall
FDA (Devices) · 2026-05-27
- HighMedtronic DLP Retrograde Cannula cardiopulmonary bypass catheter
FDA (Devices) · 2026-05-27
- HighTangent Single Use Digital Catheter Recalled for Distal Shaft Fractures
FDA (Devices) · 2026-05-27